[Risk of development of tuberculous lesions in the lungs following treatment of tuberculous pleural effusion].
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004361:Drug Tolerance; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010996:Pleural Effusion / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000209:etiology*
D000995:Antitubercular Agents
Ryzyko rozwoju zmian gruźliczych w płucach po leczeniu swoistego wysiekowego zapalenia opłucnej.